Constriction of the ductus arteriosus by selective inhibition of cyclooxygenase-1 and -2 in near-term and preterm fetal rats

Prostaglandins and Other Lipid Mediators

Volumn 79, Issue 1-2, 2006, Pages 34-42

  Toyoshima, Katsuaki ^a,b   Takeda, Atsuhito ^a,c   Imamura, Shinichiro ^a   Nakanishi, Toshio ^a   Momma, Kazuo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase; Ductus arteriosus; Fetus; Inhibitors of cyclooxygenase 2; Rat

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; INDOMETACIN; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DUCTUS ARTERIOSUS; ENZYME INHIBITION; FEMALE; FETUS; GESTATION PERIOD; IN VIVO STUDY; MALE; NONHUMAN; PREMATURITY; RAT; TOCOLYSIS;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DUCTUS ARTERIOSUS, PATENT; FEMALE; FETAL DISEASES; FETUS; PREGNANCY; RATS; RATS, WISTAR; TOCOLYSIS; VASOCONSTRICTION;

EID: 33644513740     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2004.11.005     Document Type: Article

References (33)

1. A.M. Rudolph Congenital diseases of the heart 2nd ed. 2001 Futura Armonk, NY pp. 155-196
2. F. Coceani, and P.M. Olley The response of the ductus arteriosus to prostaglandins Can J Physiol Pharmacol 51 1973 220 225
3. K. Momma, S. Uemura, S. Nishihara, and Y. Ota Dilatation of the ductus arteriosus by prostaglandins and prostaglandin's precursor Pediatr Res 14 1980 1074 1077
4. J.R. Vane, Y.S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Ann Rev Pharmacol Toxicol 38 1998 97 120
5. B. Cryer, and M. Feldman Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs Am J Med 104 1998 413 421
6. T.D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J.A. Michell, and J.R. Vane Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis Proc Natl Acad Sci USA 96 1999 7563 7568
7. R.E. Besinger, J.R. Neibyl, W.G. Keyes, and T.R. Jphnson Randomized comparative trials of indomethacin and ritodorine for the long-term treatment of preterm labor Am J Obstet Gynecol 164 1991 981 988
8. C.J. Smith, Y. Zhang, and C.M. Koboldt Pharmacological analysis of cyclooxygenase-1 in inflammation Proc Natl Acad Sci USA 95 1998 13313 13318
9. G.A. FitzGerald, and C. Patrono The coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 345 2001 433 442
10. R. Sawdy, D. Slater, N. Fisk, D.K. Edmonds, and P. Bennett Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery Lancet 350 1997 265 266
11. A.M. Guerguerian, P. Hardy, and M. Bhattacharya Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs Am J Obstet Gynecol 179 1998 1618 1626
12. F. Coceani, C. Ackerley, E. Seidlitz, and L. Kelsey Function of cyclooxygenase-1 and cyclooxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin Br J Pharmacol 132 2001 241 251
13. R.I. Clyman, P. Hardy, and N. Waleh Cycloxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus Am J Physiol 276 1999 R913 R921
14. Y. Takahashi, C. Roman, and S. Chemtob Cyclooxygenase-2 inhibitors constricts the fetal lamb ductus arteriosus both in vitro and in vivo Am J Physiol Regulatory Integrative Comp Physiol 278 2000 R1496 R1505
15. C.D. Loftin, D.B. Trivedi, and R. Langenbach Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus J Clin Invest 110 2002 549 557
16. K. Momma, and H. Takeuchi Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drug Prostaglandins 26 1983 631 643
17. K. Momma, H. Hagiwara, and T. Konishi Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drug: study of additional 34 drugs Prostaglandins 28 1984 527 536
18. K. Momma, and A. Takao Transplacental cardiovascular effects of four popular analgesics in rats Am J Obstet Gynecol 162 1990 1304 1310
19. K. Momma, T. Konishi, and H. Hagiwara Characteristic morphology of the constricted ductus arteriosus following maternal administration of indomethacin Pediatr Res 19 1985 493 500
20. S. Wallenstein, C.L. Zucker, and J.L. Fleiss Some statistical methods used in circulation research Circ Res 47 1980 1 9
21. K. Momma, and M. Toyono The role of nitric oxide in dilating the fetal ductus arteriosus in rats Pediatr Res 46 1999 311 315
22. B. Baragatti, F. Brizzi, C. Ackerley, S. Barogi, L.R. Ballou, and F. Coceani Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase Br J Pharmacol 139 2003 1505 1515
23. R.I. Clyman, F. Mauray, C. Roman, A.M. Rudolph, and M.A. Heymann Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs J Pediatr 97 1980 455 461
24. D.M. Slater, L.C. Berger, R. Newton, G.E. Moore, and P.R. Bennet Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term Am J Obstet Gynecol 172 1995 77 82
25. D. Slater, W. Dennes, R. Sawdy, V. Allport, and P. Bennett Expression of cyclooxygenase types 1 and 2 in human fetal membranes throughout pregnancy J Mol Endocrinol 22 1999 125 130
26. J. Wimsatt, P.W. Nathanielsz, and J. Sirois Induction of prostaglandin endoperoxide synthase isoform-2 in ovine cotyledonary tissues during late gestation Endocrinology 133 1993 1068 1073
27. J. Zuo, Z.M. Lei, C.V. Rao, M. Pietrntoni, and V.D. Cook Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries J Clin Endocrinol Metab 79 1994 894 899
28. L. Peruzzi, B. Gianoglio, M.G. Porcellini, and R. Coppo Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytics Lancet 354 1999 1615
29. R.P. Holmes, and P.R. Stone Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide Obstet Gynecol 96 2000 810 811
30. D.M. Paternoster, D. Snijders, F. Manganelli, A. Torrisi, and R. Bracciante Anhydramnios and maternal thrombocytopenia after prolonged use of nimesulide Eur J Obstet Gynecol Reprod Biol 108 2003 97 98
31. A. Locatelli, P. Vergani, P. Bellini, N. Strobelt, and A. Ghidini Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? Br J Obst Gynecol 108 2001 325 326
32. H. Kajino, C. Roman, and R.I. Clyman Renal effects of cyclooxygenase-2 inhibition in fetal lambs Biol Neonate 82 2002 257 262
33. C.D. Loftin, D.B. Trivedi, and H.F. Tiano Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2 Proc Natl Acad Sci USA 98 2001 1059 1064